Photo from wikipedia
Key Points Many patients who are “MRD negative” by standard MFC have clinically significant MRD that is detectable with an ultrasensitive NGS assay. Early achievement of MRD negativity using a… Click to show full abstract
Key Points Many patients who are “MRD negative” by standard MFC have clinically significant MRD that is detectable with an ultrasensitive NGS assay. Early achievement of MRD negativity using a high-sensitivity NGS assay identifies patients who have a very low risk of relapse.
Keywords:
patients low;
high sensitivity;
identifies patients;
risk relapse;
low risk
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!